Cited by 153Lipid metabolism and disordersLipid metabolism and biosynthesisCholesterol and Lipid Metabolism

Structure-Function Relationship of Lipoprotein Lipase-mediated Enhancement of Very Low Density Lipoprotein Binding and Catabolism by the Low Density Lipoprotein Receptor

Open access
Salinelli, Simona, Lo, Jing-Yi, Mims, Martha P., Zsigmond, Eva, Smith, Louis C., Chan, Lawrence·1996·Journal of Biological Chemistry

Abstract

We examined the structure-function relationship of human lipoprotein lipase (hLPL) in its ability to enhance the binding and catabolism of very low density lipoproteins (VLDL) in COS cells. Untransfected COS cells did not bind to or catabolize normal VLDL. Expression of wild-type hLPL by transient transfection enhanced binding, uptake, and degradation of the VLDL (a property of LPL that we call bridge function). Heparin pretreatment and a monoclonal antibody ID7 that blocks LDL receptor-binding domain of apoE both inhibited binding, and apoE2/E2 VLDL from a Type III hyperlipidemic subject did not bind. However, LDL did not reduce 125I-VLDL binding to the hLPL-expressing cells, whereas rabbit beta-VLDL was an effective competitor. By contrast, LDL reduced uptake and degradation of 125I-VLDL to the same extent as excess unlabeled VLDL or beta-VLDL. These data suggest that binding occurs by direct interaction of VLDL with LPL but the subsequent catabolism of the VLDL is mediated by the LDL receptor. Mutant hLPLs that were catalytically inactive, S132A, S132D, as well as the partially active mutant, S251T, and S172G, gave normal enhancement of VLDL binding and catabolism, whereas the partially active mutant S172D had markedly impaired capacity for the process; thus, there is no correlation between bridge function and lipolytic activity. A naturally occurring genetic variant hLPL, S447-->Ter, has normal bridge function. The catalytic center of LPL is covered by a 21-amino acid loo…

Integrity signals

Registry

Crossref · 10.1074/jbc.271.36.21906

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The increased levels of plasma LPL following gene transfer may promote lipoprotein clearance both by increasing the rate of lipolysis and exposing the receptor-binding domain of apoE, as well as by direct receptor-mediated clearance mechanisms involving LPL.

    “The increased levels of plasma LPL following gene transfer may promote lipoprotein clearance both by increasing the rate of lipolysis and exposing the receptor-binding domain of apoE, as well as by direct receptor-mediated clearance mechanisms involving LPL ( 38,39 ).”

Cited by

Sorted by citations

Authors
Salinelli, S., Lo, J.-Y., Mims, M. P., Zsigmond, E., Smith, L. C., & Chan, L.
Affiliations
Baylor College of Medicine (US)
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
1996-09
Volume
271
Issue
36
Pages
21906-21913
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2026299299
Cited by
153
References
0
Citations by year
2019: 1 · 2018: 1 · 2015: 2 · 2014: 5 · 2013: 2
FWCI
9.36
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Heart, Lung, and Blood Institute (HL16512, HL27341, R01HL046860, HL-46860)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
lipoprotein lipase, VLDL, LDL receptor, VLDL catabolism, bridge function, apolipoprotein E, type III hyperlipidemia, catalytic loop, heparin
MeSH terms
Animals, Apolipoproteins B, Apolipoproteins E, Binding Sites, Catalysis, Cricetulus, Enzyme-Linked Immunosorbent Assay, Cricetinae, Humans, Lipoprotein Lipase, Lipoproteins, LDL, Lipoproteins, VLDL, Rabbits, Receptors, LDL, Structure-Activity Relationship, Transfection, Point Mutation, Protein Structure, Tertiary, Apolipoprotein B-100

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review